Posted in | News | Lighting

Fagerhult to Acquire Lighting Innovations Based in Port Elisabeth, South Africa

In order to establish the Fagerhult Group (STO:FAG) in the South African market and in the Sub Saharan region, Fagerhult has signed an agreement to acquire the assets of Lighting Innovations based in Port Elisabeth, South Africa, including their subsidiary companies Beacon Lighting and Arrow Lighting. The acquisition is expected to have a positive effect on the earnings per share during 2016 and forward.

The three companies have 210 employees and manufacture lighting fixtures and solutions primarily for the indoor commercial sector. Typical application areas include commercial offices, retail, hospitals and educational buildings. In the year ending June 2015, the companies had a combined sales of approximately 13 MEUR.

“One key element of our strategy is to increase our market position in emerging markets. With this acquisition we gain access to the South African market and several interesting growth opportunities within the dynamic Sub Saharan Africa region. I am also very pleased that Mr. Craig Waddell will remain with the company in the position of Managing Director and continue to build on the strong platform that he and especially his father, Mr. Bruce Waddell, has established since founding the company”, comments Johan Hjertonsson CEO Fagerhult.

Fagerhult pays MEUR 8,6, on a cash and debt free basis, for the assets of the three companies. The deal is expected to close in the 2nd half of 2015. An additional earnout can be paid until 2018 tied to the company performance. The transaction is financed with new credit facilities.

More information on Lighting Innovation is available at www.lightinginnovation.co.za.

Source: http://www.fagerhult.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.